CoQ10 exerts hepatoprotective effect in fructose-induced fatty liver model in rats.

Abstract

Excess dietary sugar is associated with deleterious metabolic effects, liver injury, and coenzyme-Q10 (CoQ10) deficiency. This study investigates the ability of CoQ10 to protect against fructose-induced hepatic damage. Rats were fed tap water or 30% fructose for 12weeks with or without CoQ10 (10mg/kg, po). An additional group of rats were allowed to feed on either water or 30% fructose for 12weeks, followed by four weeks of treatment with either the vehicle or CoQ10. Fructose-fed rats showed lower CoQ10 levels, increased systolic pressure, increased body weight, higher liquid consumption, decreased food intake and hyperglycemia. Fructose-fed rats also showed deteriorated serum and liver lipid profiles, impaired liver function tests and oxidative status, and lower expression of adiponectin receptor 1 and 2 along with higher GLUT-2 levels. Furthermore, following fructose treatment, tyrosine kinase-PI3K pathway was inhibited. Additionally, there was an increase in the levels of apoptotic markers and serum visfatin and a decrease in the levels of adiponectin and soluble receptor of the advanced glycated end product. Consequently, several histopathological changes were detected in the liver. Concurrent or three months post-exposure administration of CoQ10 in fructose rats significantly reversed or attenuated all the measured parameters and hepato-cytoarchitecture alterations. This study suggests CoQ10 supplement as a possible prophylaxis or treatment candidate for fructose-induced liver injury.